| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |